Views Navigation

Event Views Navigation

Today

Building Capacity for a Public Health Approach to Prevention

COURSE DESCRIPTION Substance misuse and behavioral health overall, are an intrinsic part of public health. Many people with substance use disorders also live with mental health disorders, including serious mental […]

Understanding the New Changes to 42 CFR Part 2

On July 15, 2020, SAMHSA finalized changes to 42 CFR Part 2 ("Part 2"), the regulations for the Confidentiality of Substance Use Disorder Patient Records. These changes will go into […]

Prevention of Opioid Use Disorder in Women

Marjorie Meyer, MD, Associate Professor, Maternal Fetal Medicine, University of Vermont, Burlington, VT . Women are at particularly increased risk of developing opioid use disorder related to prescribed opioids.  This webinar will […]

Best Practices for Co-occurring Disorders Treatment: Staffing and Training

Organizational staffing directly impacts program capacity for integrated treatment, particularly whether an organization’s staff composition includes staff with dual licensure or extensive experience treating individuals with co-occurring disorders. This webinar […]

Deconstructing Unconscious Bias in Behavioral Health Care

Description: Behavioral health disparities reflect the lack of access to quality care for specific populations. Despite notable efforts to address inequitable outcomes, research suggests that race and ethnicity are predictors […]

Supporting Recovery for All: Racial Equity in Recovery

Anecdotal evidence suggests that even with a growing number of Black recovery leaders and Black-led recovery organizations, Black people continue to be underrepresented and underserved within recovery support settings. SAMHSA’s […]

Treatment of Stimulant Use Disorders

Presenter: Richard Rawson, PhD, Research Professor, Vermont Center for Behavior and Health, University of Vermont in Burlington, VT and Professor Emeritus, UCLA Department of Psychiatry, Los Angeles, CA Summary: The emergence of increased rates of cocaine and methamphetamine use and associated overdose deaths (with and without opioids) is being referred to as the “4th wave of the opioid […]

Advocacy Series, Session IV: Confidentiality Rule Changes and 42 CFR

Description This webinar will review the latest legislation on 42 USC 290dd-2(b), which migrates a portion of the substance use disorder confidentiality regulations into HIPAA. Participants will be presented with both the update and a discussion of the integration of the amended 42 USC 290dd-2. In addition, a review of the most current regulations put […]

Making the Case to Identify Not Blame: Deconstructing Unconscious Bias in Behavioral Health Care Series

Description: Building off the psychological framework of unconscious bias as discussed in the first session, this second presentation will review and inform on how unconscious bias is reflected in words, communications, and relations toward persons of color through case scenarios reflecting its impact in the addiction, mental health, and prevention settings. The elusiveness of cognitive […]